- Home
- GAIN vs HQL Comparison
GAIN vs HQL Comparison
Compare GAIN & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- HQL
- Stock Information
- Founded
- GAIN 2005
- HQL 1992
- Country
- GAIN United States
- HQL United States
- Employees
- GAIN N/A
- HQL N/A
- Industry
- GAIN Finance: Consumer Services
- HQL Investment Managers
- Sector
- GAIN Finance
- HQL Finance
- Exchange
- GAIN Nasdaq
- HQL Nasdaq
- Market Cap
- GAIN 522.8M
- HQL 440.3M
- IPO Year
- GAIN 2005
- HQL N/A
- Fundamental
- Price
- GAIN $13.98
- HQL $16.36
- Analyst Decision
- GAIN Buy
- HQL
- Analyst Count
- GAIN 2
- HQL 0
- Target Price
- GAIN $14.00
- HQL N/A
- AVG Volume (30 Days)
- GAIN 157.4K
- HQL 120.9K
- Earning Date
- GAIN 11-04-2025
- HQL 01-01-0001
- Dividend Yield
- GAIN 15.67%
- HQL 11.56%
- EPS Growth
- GAIN 8.96
- HQL N/A
- EPS
- GAIN 2.16
- HQL 0.79
- Revenue
- GAIN $95,028,000.00
- HQL N/A
- Revenue This Year
- GAIN $6.54
- HQL N/A
- Revenue Next Year
- GAIN $4.49
- HQL N/A
- P/E Ratio
- GAIN $6.49
- HQL $17.08
- Revenue Growth
- GAIN 6.55
- HQL N/A
- 52 Week Low
- GAIN $11.42
- HQL $11.34
- 52 Week High
- GAIN $15.34
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- GAIN 54.46
- HQL 66.52
- Support Level
- GAIN $13.71
- HQL $16.21
- Resistance Level
- GAIN $14.06
- HQL $16.92
- Average True Range (ATR)
- GAIN 0.30
- HQL 0.31
- MACD
- GAIN 0.05
- HQL -0.02
- Stochastic Oscillator
- GAIN 97.23
- HQL 59.28
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.